Transfusion-related acute lung injury: incidence and risk factors

Pearl Toy(University of California, San Francisco), Ognjen Gajic(Mayo Clinic in Arizona), Peter Bacchetti(University of California, San Francisco), Mark R. Looney(University of California, San Francisco), Michael A. Gropper(University of California, San Francisco), Rolf D. Hubmayr(Mayo Clinic in Arizona), Clifford A. Lowell(University of California, San Francisco), Philip J. Norris(University of California, San Francisco), Edward L. Murphy(University of California, San Francisco), Richard B. Weiskopf(University of California, San Francisco), Gregory Wilson(Mayo Clinic in Arizona), Monique Koenigsberg(University of California, San Francisco), Deanna Lee(University of California, San Francisco), Randy M. Schuller(American Red Cross), Ping Wu(University of California, San Francisco), Barbara Grimes(University of California, San Francisco), Manish J. Gandhi(Mayo Clinic in Arizona), Jeffrey L. Winters(Mayo Clinic in Arizona), David Mair(American Red Cross), Nora V. Hirschler(University of California, San Francisco), Rosa Sanchez Rosen(University of California, San Francisco), Michael A. Matthay(University of California, San Francisco), for the TRALI Study Group
Blood
November 24, 2011
Cited by 562Open Access
Full Text

Abstract

Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. To determine TRALI incidence by prospective, active surveillance and to identify risk factors by a case-control study, 2 academic medical centers enrolled 89 cases and 164 transfused controls. Recipient risk factors identified by multivariate analysis were higher IL-8 levels, liver surgery, chronic alcohol abuse, shock, higher peak airway pressure while being mechanically ventilated, current smoking, and positive fluid balance. Transfusion risk factors were receipt of plasma or whole blood from female donors (odds ratio = 4.5, 95% confidence interval [CI], 1.85-11.2, P = .001), volume of HLA class II antibody with normalized background ratio more than 27.5 (OR = 1.92/100 mL, 95% CI, 1.08-3.4, P = .03), and volume of anti-human neutrophil antigen positive by granulocyte immunofluoresence test (OR = 1.71/100 mL, 95% CI, 1.18-2.5, P = .004). Little or no risk was associated with older red blood cell units, noncognate or weak cognate class II antibody, or class I antibody. Reduced transfusion of plasma from female donors was concurrent with reduced TRALI incidence: 2.57 (95% CI, 1.72-3.86) in 2006 versus 0.81 (95% CI, 0.44-1.49) in 2009 per 10 000 transfused units (P = .002). The identified risk factors provide potential targets for reducing residual TRALI.


Related Papers

No related papers found

Powered by citation graph analysis